Prager GW - Search Results

1

Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.

Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.

2

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review.

Arnold D, Prager GW, Quintela A, Stein A, Moreno Vera S, Mounedji N, Taieb J. Arnold D, et al. Among authors: prager gw. Ann Oncol. 2018 Apr 1;29(4):835-856. doi: 10.1093/annonc/mdy038. Ann Oncol. 2018. PMID: 29452346 Free PMC article.

3

Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.

Unseld M, Drimmel M, Siebenhüner A, Gleiss A, Bianconi D, Kieler M, Scheithauer W, Winder T, Prager GW. Unseld M, et al. Among authors: prager gw. Clin Colorectal Cancer. 2018 Dec;17(4):274-279. doi: 10.1016/j.clcc.2018.05.012. Epub 2018 Jun 8. Clin Colorectal Cancer. 2018. PMID: 30042010

4

Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.

Bekaii-Saab T, Kim R, Kim TW, O'Connor JM, Strickler JH, Malka D, Sartore-Bianchi A, Bi F, Yamaguchi K, Yoshino T, Prager GW. Bekaii-Saab T, et al. Among authors: prager gw. Clin Colorectal Cancer. 2019 Mar;18(1):e117-e129. doi: 10.1016/j.clcc.2018.11.002. Epub 2018 Nov 16. Clin Colorectal Cancer. 2019. PMID: 30598357 Free article. Review.

5

Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence.

Seufferlein T, Hammel P, Delpero JR, Macarulla T, Pfeiffer P, Prager GW, Reni M, Falconi M, Philip PA, Van Cutsem E. Seufferlein T, et al. Among authors: prager gw. Cancer Treat Rev. 2019 Jul;77:1-10. doi: 10.1016/j.ctrv.2019.05.007. Epub 2019 May 29. Cancer Treat Rev. 2019. PMID: 31163334 Review.

6

Maximising clinical benefit with adequate patient management beyond the second line in mCRC.

Argiles G, Arnold D, Prager G, Sobrero AF, Van Cutsem E. Argiles G, et al. ESMO Open. 2019 May 13;4(2):e000495. doi: 10.1136/esmoopen-2019-000495. eCollection 2019. ESMO Open. 2019. PMID: 31231561 Free PMC article. Review.

7

Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.

Scheithauer W, Putora PM, Grünberger B, Eisterer W, Wöll E, Prager G, Schaberl-Moser R, Greil R, Glatzer M. Scheithauer W, et al. Therap Adv Gastroenterol. 2019 Sep 23;12:1756284819877635. doi: 10.1177/1756284819877635. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31579123 Free PMC article.

8

First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study.

Taieb J, Prager GW, Melisi D, Westphalen CB, D'Esquermes N, Ferreras A, Carrato A, Macarulla T. Taieb J, et al. Among authors: prager gw. ESMO Open. 2020 Jan;5(1):e000587. doi: 10.1136/esmoopen-2019-000587. ESMO Open. 2020. PMID: 31958291 Free PMC article. Review.

9

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.

Riedl JM, Posch F, Prager G, Eisterer W, Oehler L, Sliwa T, Wilthoner K, Petzer A, Pichler P, Hubmann E, Winder T, Burgstaller S, Korger M, Andel J, Greil R, Neumann HJ, Pecherstorfer M, Philipp-Abbrederis K, Djanani A, Gruenberger B, Laengle F, Wöll E, Gerger A. Riedl JM, et al. Ther Adv Med Oncol. 2020 Apr 10;12:1758835919900872. doi: 10.1177/1758835919900872. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32313566 Free PMC article.

10

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients.

Unseld M, Fischöder S, Jachs M, Drimmel M, Siebenhüner A, Bianconi D, Kieler M, Puhr H, Minichsdorfer C, Winder T, Prager GW. Unseld M, et al. Among authors: prager gw. J Clin Med. 2020 Jun 7;9(6):1772. doi: 10.3390/jcm9061772. J Clin Med. 2020. PMID: 32517383 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page